Lobelia inflata
Lobelia inflata · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Lobelia inflata is a unique botanical species known for its complex chemical profile, most notably containing the alkaloid lobeline. Recent scientific investigations have highlighted its diverse pharmacological potential, including roles as an ACE-inhibitor and an AP-1-inhibitor. Furthermore, the plant demonstrates significant biological activity as a 5-alpha-reductase inhibitor. Emerging research also points toward its anticancer properties, particularly in its ability to influence cellular responses to Doxorubicin. These multifaceted activities make it a subject of intense interest in the study of therapeutic plant compounds.
- Synonyms
- Lobelia Michauxii · Lobelia Inflata Var. Simplex · 4 more
- Common names
- Not available
- Family
- Campanulaceae
- Distribution
- Asia-Tropical
- Plant Parts
- Not available
Classification
Common Names
Lobelia inflata is a versatile plant recognized by several distinct regional and traditional names. In some areas, it is known by the common name Blaaslobelia, while others refer to it as Erva-da-asma. It is also widely identified by the name Indian tobacco, a term that appears in various forms such as Indian-tobacco or Indian-tobacco (EN). These diverse monikers reflect the plant's broad cultural significance across different linguistic backgrounds. Understanding these various names is essential for anyone studying the botanical heritage of this species.
Sources: Catalogue of Life (COL)
Synonyms
Lobelia inflata is a species recognized by several different botanical names throughout scientific history. It has been formally identified under various synonyms, including the names Dortmanna inflata and Lobelia michauxii. Taxonomists have also classified specific forms of the plant as Lobelia inflata f. albiflora and Lobelia inflata var. simplex. Furthermore, the species is linked to the synonym Rapuntium inflatum in certain botanical records. Understanding these various nomenclatural relationships is essential for accurately identifying the plant across different studies.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Lobelia inflata is a member of the kingdom Plantae, representing the diverse life found within the plant world. This species belongs to the class Equisetopsida and is classified under the order Asterales. Within this botanical hierarchy, it is further organized into the family Campanulaceae. It is more specifically identified as a part of the genus Lobelia. Through these scientific relationships, its unique place in nature is clearly defined.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Campanulaceae |
| Genus | Lobelia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Lobelia inflata exhibits a remarkably broad geographic distribution that spans multiple continents and diverse climates. In Asia, the species is well-established throughout the temperate regions, including specific populations found in Japan. Its presence extends across Europe, where it is commonly documented within the central landscapes of Germany. Moving to North America, the plant thrives in the eastern reaches of Canada, appearing in provinces such as New Brunswick and Nova Scotia. Furthermore, its resilient nature allows it to flourish throughout the varied environments of Ontario.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Lobelia inflata grows in a classic herb form, characterized by its delicate yet resilient structure. This plant is entirely self-supporting, allowing it to maintain its upright presence within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Lobelia inflata is one of several traditional medicinal plants identified for its potential role in modern anticancer drug development. Scientific investigation into these botanical resources focuses on how their bioactive compounds can modulate complex signaling pathways associated with lung and colorectal cancers. Within this plant, specific phytoconstituents such as lobeline are being studied for their ability to influence critical cellular processes in vitro. By exploring these natural products, researchers aim to bridge the gap between ancient traditional knowledge and contemporary oncological science. Ultimately, the integration of such plant-based compounds offers a promising avenue for creating innovative therapeutic strategies against aggressive cancer types.
Compounds
Lobelia inflata serves as a natural source of lobeline, a significant piperidine alkaloid. Research indicates that this specific compound possesses the ability to inhibit P-glycoprotein activity within tumor cells. By interfering with this mechanism, lobeline can effectively reverse multidrug resistance and sensitize resistant cells to chemotherapy. While it does not impact BCRP-dependent efflux, its capacity to enhance the efficacy of drugs like doxorubicin is promising. Consequently, lobeline represents a strong candidate for the development of new agents designed to combat drug resistance in cancer treatment.
Conditions
Lobelia inflata contains lobeline, a piperidine alkaloid that treats multidrug resistance (MDR) by reversing the process in tumor cells. This plant specifically treats P-gp activity by inhibiting the P-glycoprotein mediated drug efflux mechanism. Consequently, Lobelia inflata treats P-gp dependent multidrug resistance, making it a potential candidate for new reversal agents. The plant also treats doxorubicin by sensitizing resistant tumor cells to the drug at non-toxic concentrations. Additionally, Lobelia inflata acts as a chromium concentrator that can be used to treat deficiency in humans.